| http://www.w3.org/ns/prov#value | - Immunosuppressive protocols for inhibiting allogeneic graft rejection, for example via administration of cyclosporin A, immunosuppressive antibodies, and the like are widespread and standard practice in the clinic. [0227] The present invention further envisages administration to a human subject of cultured cells derived from an animal, such as a pig, genetically engineered to avoid rejection of a
|
